Novel virostatic agents against bluetongue virus

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Gu, Linlin ^a,b   Musiienko, Volodymyr ^c   Bai, Zhijun ^b,d   Qin, Aijian ^a   Schneller, Stewart W ^c   Li, Qianjun ^b  

^a YANGZHOU UNIVERSITY   (China)

^b University of Alabama at Birmingham   (United States)

^c AUBURN UNIVERSITY   (United States)

^d GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[3 (2 FURYL)ACRYLOYL]AMINO] 4 (4 METHYLPHENYL) 3 THIOPHENECARBOXYLIC ACID; AMINOTHIOPHENECARBOXYLIC ACID DERIVATIVE; ANTIVIRUS AGENT; CASPASE 3; CASPASE 7; PROTEIN VP6; THIOPHENE DERIVATIVE; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOPHAGY; BLUETONGUE ORBIVIRUS; CC 50; CELL PROTECTION; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CONCENTRATION; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVATION; ENZYME INHIBITION; LIFE CYCLE STAGE; MEDIAN EFFECTIVE CONCENTRATION; NONHUMAN; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; VIROSTATIC ACTIVITY; VIRUS GENOME; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; APOPTOSIS; AUTOPHAGY; BLUETONGUE; BLUETONGUE VIRUS; CASPASE 3; CASPASE 7; CELL LINE; CELL SURVIVAL; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; INHIBITORY CONCENTRATION 50; MODELS, CHEMICAL; RNA, VIRAL; THIOPHENES;

EID: 84865049551     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043341     Document Type: Article

References (80)

1. Li Q, Li H, Blitvich BJ, Zhang J, (2007) The Aedes albopictus inhibitor of apoptosis 1 gene protects vertebrate cells from bluetongue virus-induced apoptosis. Insect Mol Biol 16: 93-105.
2. Schwartz-Cornil I, Mertens PP, Contreras V, Hemati B, Pascale F, et al. (2008) Bluetongue virus: virology, pathogenesis and immunity. Vet Res 39: 46.
3. Forzan M, Marsh M, Roy P, (2007) Bluetongue virus entry into cells. J Virol 81: 4819-4827.
4. Mellor PS, Wittmann EJ, (2002) Bluetongue virus in the Mediterranean Basin 1998-2001. Vet J 164: 20-37.
5. Paweska JT, Venter GJ, Mellor PS, (2002) Vector competence of South African Culicoides species for bluetongue virus serotype 1 (BTV-1) with special reference to the effect of temperature on the rate of virus replication in C. imicola and C. bolitinos. Med Vet Entomol 16: 10-21.
6. Mellor PS, Carpenter S, Harrup L, Baylis M, Mertens PP, (2008) Bluetongue in Europe and the Mediterranean Basin: history of occurrence prior to 2006. Prev Vet Med 87: 4-20.
7. Mertens PP, Diprose J, Maan S, Singh KP, Attoui H, et al. (2004) Bluetongue virus replication, molecular and structural biology. Vet Ital 40: 426-437.
8. MacLachlan NJ, Conley AJ, Kennedy PC, (2000) Bluetongue and equine viral arteritis viruses as models of virus-induced fetal injury and abortion. Anim Reprod Sci 60-61: 643-651.
9. Roy P, (2005) Bluetongue virus proteins and particles and their role in virus entry, assembly, and release. Adv Virus Res 64: 69-123.
10. Roy P, (2008) Functional mapping of bluetongue virus proteins and their interactions with host proteins during virus replication. Cell Biochem Biophys 50: 143-157.
11. Roy P, (2008) Bluetongue virus: dissection of the polymerase complex. J Gen Virol 89: 1789-1804.
12. Boyce M, Celma CC, Roy P, (2008) Development of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts. J Virol 82: 8339-8348.
13. Boyce M, Roy P, (2007) Recovery of infectious bluetongue virus from RNA. J Virol 81: 2179-2186.
14. Matsuo E, Roy P, (2009) Bluetongue virus VP6 acts early in the replication cycle and can form the basis of chimeric virus formation. J Virol 83: 8842-8848.
15. Maclachlan NJ, Drew CP, Darpel KE, Worwa G, (2009) The pathology and pathogenesis of bluetongue. J Comp Pathol 141: 1-16.
16. Szmaragd C, Wilson AJ, Carpenter S, Wood JL, Mellor PS, et al. (2010) The spread of bluetongue virus serotype 8 in Great Britain and its control by vaccination. PLoS One 5: e9353.
17. De A, Batabyal S, Biswas SK, Chand K, Singh RK, et al. (2009) Surveillance of bluetongue virus antibody in goats using a recombinant VP7-based indirect ELISA in the coastal saline area of West Bengal, India. Vet Ital 45: 339-346.
18. Bhanuprakash V, Indrani BK, Hosamani M, Balamurugan V, Singh RK, (2009) Bluetongue vaccines: the past, present and future. Expert Rev Vaccines 8: 191-204.
19. Wackerlin R, Eschbaumer M, Konig P, Hoffmann B, Beer M (2010) Evaluation of humoral response and protective efficacy of three inactivated vaccines against bluetongue virus serotype 8 one year after vaccination of sheep and cattle. Vaccine.
20. Dungu B, Potgieter C, Von Teichman B, Smit T, (2004) Vaccination in the control of bluetongue in endemic regions: the South African experience. Dev Biol (Basel) 119: 463-472.
21. Santman-Berends IM, Hage JJ, van Rijn PA, Stegeman JA, van Schaik G, (2010) Bluetongue virus serotype 8 (BTV-8) infection reduces fertility of Dutch dairy cattle and is vertically transmitted to offspring. Theriogenology 74: 1377-1384.
22. Saegerman C, Mellor P, Uyttenhoef A, Hanon JB, Kirschvink N, et al. (2010) The most likely time and place of introduction of BTV8 into Belgian ruminants. PLoS One 5: e9405.
23. Wilson AJ, Mellor PS, (2009) Bluetongue in Europe: past, present and future. Philos Trans R Soc Lond B Biol Sci 364: 2669-2681.
24. Vandenbussche F, De Leeuw I, Vandemeulebroucke E, De Clercq K, (2009) Emergence of bluetongue serotypes in Europe, part 1: description and validation of four real-time RT-PCR assays for the serotyping of bluetongue viruses BTV-1, BTV-6, BTV-8 and BTV-11. Transbound Emerg Dis 56: 346-354.
25. Mehlhorn H, Walldorf V, Klimpel S, Schaub G, Kiel E, et al. (2009) Bluetongue disease in Germany (2007-2008): monitoring of entomological aspects. Parasitol Res 105: 313-319.
26. Mehlhorn H, Walldorf V, Klimpel S, Schmahl G, (2008) Outbreak of bluetongue disease (BTD) in Germany and the danger for Europe. Parasitol Res 103 (Suppl 1): S79-86.
27. Meiswinkel R, Goffredo M, Dijkstra EG, van der Ven IJ, Baldet T, et al. (2008) Endophily in Culicoides associated with BTV-infected cattle in the province of Limburg, south-eastern Netherlands, 2006. Prev Vet Med 87: 182-195.
28. Toussaint JF, Sailleau C, Breard E, Zientara S, De Clercq K, (2007) Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments. J Virol Methods 140: 115-123.
29. Enserink M, (2006) Emerging infectious diseases. During a hot summer, bluetongue virus invades northern Europe. Science 313: 1218-1219.
30. Meroc E, Herr C, Verheyden B, Hooyberghs J, Houdart P, et al. (2009) Bluetongue in Belgium: episode II. Transbound Emerg Dis 56: 39-48.
31. Worwa G, Hilbe M, Chaignat V, Hofmann MA, Griot C, et al. (2010) Virological and pathological findings in Bluetongue virus serotype 8 infected sheep. Vet Microbiol.
32. Worwa G, Thur B, Griot C, Hofmann M, MacLachlan JN, et al. (2008) [Bluetongue disease in Swiss sheep breeds: clinical signs after experimental infection with bluetongue virus serotype 8]. Schweiz Arch Tierheilkd 150: 491-498.
33. Jonsson CB, White EL (2007) Launching an HTS campaign to discover new antivirals. European Pharmaceutical Review: 4.
34. Li Q, Maddox C, Rasmussen L, Hobrath JV, White LE, (2009) Assay development and high-throughput antiviral drug screening against Bluetongue virus. Antiviral Res 83: 267-273.
35. Phillips T, Jenkinson L, McCrae C, Thong B, Unitt J, (2011) Development of a high-throughput human rhinovirus infectivity cell-based assay for identifying antiviral compounds. J Virol Methods 173: 182-188.
36. Noah JW, Severson W, Noah DL, Rasmussen L, White EL, et al. (2007) A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals. Antiviral Res 73: 50-59.
37. Mortola E, Larsen A, (2009) [Bluetongue virus infection: signaling pathway activated during apoptosis]. Rev Argent Microbiol 41: 134-140.
38. Stauber N, Martinez-Costas J, Sutton G, Monastyrskaya K, Roy P, (1997) Bluetongue virus VP6 protein binds ATP and exhibits an RNA-dependent ATPase function and a helicase activity that catalyze the unwinding of double-stranded RNA substrates. J Virol 71: 7220-7226.
39. Cherra SJ, 3rd, Dagda RK, Chu CT (2010) Review: autophagy and neurodegeneration: survival at a cost? Neuropathol Appl Neurobiol 36: 125-132.
40. Singletary K, Milner J, (2008) Diet, autophagy, and cancer: a review. Cancer Epidemiol Biomarkers Prev 17: 1596-1610.
41. Larsen KE, Sulzer D, (2002) Autophagy in neurons: a review. Histol Histopathol 17: 897-908.
42. Wileman T, (2006) Aggresomes and autophagy generate sites for virus replication. Science 312: 875-878.
43. Law AH, Lee DC, Yuen KY, Peiris M, Lau AS, (2010) Cellular response to influenza virus infection: a potential role for autophagy in CXCL10 and interferon-alpha induction. Cell Mol Immunol 7: 263-270.
44. Rossman JS, Lamb RA, (2009) Autophagy, apoptosis, and the influenza virus M2 protein. Cell Host Microbe 6: 299-300.
45. Zhou Z, Jiang X, Liu D, Fan Z, Hu X, et al. (2009) Autophagy is involved in influenza A virus replication. Autophagy 5: 321-328.
46. Dreux M, Chisari FV, (2009) Autophagy proteins promote hepatitis C virus replication. Autophagy 5: 1224-1225.
47. Dreux M, Gastaminza P, Wieland SF, Chisari FV, (2009) The autophagy machinery is required to initiate hepatitis C virus replication. Proc Natl Acad Sci U S A 106: 14046-14051.
48. Heaton NS, Randall G, (2010) Dengue virus-induced autophagy regulates lipid metabolism. Cell Host Microbe 8: 422-432.
49. Bartram DJ, Heasman L, Batten CA, Oura CA, Plana-Duran J, et al. (2011) Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines. Vet J.
50. Hamers C, Galleau S, Chery R, Blanchet M, Besancon L, et al. (2009) Use of inactivated bluetongue virus serotype 8 vaccine against virulent challenge in sheep and cattle. Vet Rec 165: 369-373.
51. Pubchem Bioassay. MLS000673879- Substance Summary (SID 24798053). http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=24798053&loc=es_rss.
52. Clarke TE, Clem RJ, (2003) Insect defenses against virus infection: the role of apoptosis. Int Rev Immunol 22: 401-424.
53. Everett H, McFadden G, (1999) Apoptosis: an innate immune response to virus infection. Trends Microbiol 7: 160-165.
54. Koyama AH, Irie H, Fukumori T, Hata S, Iida S, et al. (1998) Role of virus-induced apoptosis in a host defense mechanism against virus infection. J Med Invest 45: 37-45.
55. Stewart ME, Roy P, (2010) Role of cellular caspases, nuclear factor-kappa B and interferon regulatory factors in Bluetongue virus infection and cell fate. Virol J 7: 362.
56. Mortola E, Noad R, Roy P, (2004) Bluetongue virus outer capsid proteins are sufficient to trigger apoptosis in mammalian cells. J Virol 78: 2875-2883.
57. Nagaleekar VK, Tiwari AK, Kataria RS, Bais MV, Ravindra PV, et al. (2007) Bluetongue virus induces apoptosis in cultured mammalian cells by both caspase-dependent extrinsic and intrinsic apoptotic pathways. Arch Virol 152: 1751-1756.
58. Yorimitsu T, Klionsky DJ, (2005) Autophagy: molecular machinery for self-eating. Cell Death Differ 12 (Suppl 2): 1542-1552.
59. Fimia GM, Piacentini M, (2009) Toward the understanding of autophagy regulation and its interplay with cell death pathways. Cell Death Differ 16: 933-934.
60. Gougeon ML, Piacentini M, (2009) New insights on the role of apoptosis and autophagy in HIV pathogenesis. Apoptosis 14: 501-508.
61. Dreux M, Chisari FV Viruses and the autophagy machinery. Cell Cycle 9: 1295-1307.
62. Orvedahl A, Levine B, (2009) Eating the enemy within: autophagy in infectious diseases. Cell Death Differ 16: 57-69.
63. Lee YR, Lei HY, Liu MT, Wang JR, Chen SH, et al. (2008) Autophagic machinery activated by dengue virus enhances virus replication. Virology 374: 240-248.
64. Khakpoor A, Panyasrivanit M, Wikan N, Smith DR, (2009) A role for autophagolysosomes in dengue virus 3 production in HepG2 cells. J Gen Virol 90: 1093-1103.
65. Panyasrivanit M, Khakpoor A, Wikan N, Smith DR, (2009) Co-localization of constituents of the dengue virus translation and replication machinery with amphisomes. J Gen Virol 90: 448-456.
66. Jackson WT, Giddings TH Jr, Taylor MP, Mulinyawe S, Rabinovitch M, et al. (2005) Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol 3: e156.
67. Prentice E, Jerome WG, Yoshimori T, Mizushima N, Denison MR, (2004) Coronavirus replication complex formation utilizes components of cellular autophagy. J Biol Chem 279: 10136-10141.
68. Hyser JM, Utama B, Crawford SE, Estes MK Genetic divergence of rotavirus nonstructural protein 4 results in distinct serogroup-specific viroporin activity and intracellular punctate structure morphologies. J Virol 86: 4921-4934.
69. Berkova Z, Crawford SE, Trugnan G, Yoshimori T, Morris AP, et al. (2006) Rotavirus NSP4 induces a novel vesicular compartment regulated by calcium and associated with viroplasms. J Virol 80: 6061-6071.
70. Roy P, Noad R, (2006) Bluetongue virus assembly and morphogenesis. Curr Top Microbiol Immunol 309: 87-116.
71. Celma CC, Roy P, (2009) A viral nonstructural protein regulates bluetongue virus trafficking and release. J Virol 83: 6806-6816.
72. Harty RN, (2009) No exit: targeting the budding process to inhibit filovirus replication. Antiviral Res 81: 189-197.
73. Buchholz UJ, Finke S, Conzelmann KK, (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73: 251-259.
74. Mertens PP, Burroughs JN, Anderson J, (1987) Purification and properties of virus particles, infectious subviral particles, and cores of bluetongue virus serotypes 1 and 4. Virology 157: 375-386.
75. Kar AK, Roy P, (2003) Defining the structure-function relationships of bluetongue virus helicase protein VP6. J Virol 77: 11347-11356.
76. Landry ML, Stanat S, Biron K, Brambilla D, Britt W, et al. (2000) A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates. Antimicrob Agents Chemother 44: 688-692.
77. Hayden FG, Cote KM, Douglas RG Jr, (1980) Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob Agents Chemother 17: 865-870.
78. Sabnis RW, Rangnekar DW, Sonawane ND, (1999) 2-aminothiophenes by the Gewald reaction. Journal of Heterocyclic Chemistry 36: 333-345.
79. El-Batta A, Jiang CC, Zhao W, Anness R, Cooksy AL, et al. (2007) Wittig reactions in water media employing stabilized ylides with aldehydes. Synthesis of alpha,beta-unsaturated esters from mixing aldehydes, alpha-bromoesters, and Ph3P in aqueous NaHCO3. Journal of Organic Chemistry 72: 5244-5259.
80. Touchard FP, (2004) New and efficient conditions for the Z-selective synthesis of unsaturated esters by the Horner-Wadsworth-Emmons olefination. Tetrahedron Letters 45: 5519-5523.